Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 4/20 | 0.52 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30262213 | 0.93 | OPRM1 (0.58) | TFPIOPRM1OPRD1OPRK1BACE1 | |
| SCHEMBL30712875 | 0.90 | TFPI (0.62) | TFPIOPRM1OPRD1OPRK1BACE1 | |
| SCHEMBL30292594 | 0.89 | CTSB (0.53) | TFPIBACE1BACE2CTSB | |
| SCHEMBL30974266 | 0.89 | TFPI (0.55) | TFPIOPRM1OPRD1OPRK1BACE1 | |
| SCHEMBL30576935 | 0.89 | TFPI (0.57) | TFPIBACE1BACE2GLP1R | |
| SCHEMBL30721545 | 0.87 | GLP1R (0.58) | TFPIOPRM1OPRD1OPRK1GLP1R | |
| SCHEMBL29397161 | 0.86 | BACE1 (0.49) | OPRM1OPRD1OPRK1BACE1BACE2 | |
| SCHEMBL30974440 | 0.86 | OPRL1 (0.56) | TFPIGLP1R | |
| SCHEMBL30950136 | 0.86 | GLP1R (0.65) | TFPIGLP1R | |
| SCHEMBL31257077 | 0.85 | OPRM1 (0.57) | OPRM1OPRD1OPRK1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |